BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TAK-411 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TAK-411\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06798012-11362@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20271202
DTEND;VALUE=DATE:20271203
SUMMARY:TAK-411: Phase 2 readout est. (NCT06798012)
DESCRIPTION:TAK-411\, phase 2.\nStudy: A Study of TAK-411 in Adults With Ch
 ronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)\nEstimated 
 primary completion: 2 December 2027. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/tak-411#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT06798012
URL:https://assetmemo.bio/drug/tak-411#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
